Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tiffany Hink

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Anaerobe|December 19, 2012
A systematic evaluation of methods to optimize culture-based recovery of Clostridium difficile from stool specimensTiffany Hink, Carey-Ann D Burnham, Erik R Dubberke
Journal of Clinical Microbiology|November 21, 2014
Comparison of chromogenic media for recovery of carbapenemase-producing enterobacteriaceae (CPE) and evaluation of CPE prevalence at a tertiary care academic medical centerMorgan A Pence, Tiffany Hink, Carey-Ann D Burnham
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 24, 2014
Prevalence and risk factors for asymptomatic Clostridium difficile carriageFaisal Alasmari, Sondra M Seiler, Tiffany Hink, et al.
Journal of Clinical Microbiology|December 9, 2016
Evaluation of Correlation between Pretest Probability for Clostridium difficile Infection and Clostridium difficile Enzyme Immunoassay ResultsJennie H Kwon, Kimberly A Reske, Tiffany Hink, et al.
Antimicrobial Agents and Chemotherapy|August 19, 2015
Ceftolozane-tazobactam activity against phylogenetically diverse Clostridium difficile strainsMark D Gonzalez, Meghan A Wallace, Tiffany Hink, et al.
Infection Control and Hospital Epidemiology|October 25, 2019
Impact of an electronic hard-stop clinical decision support tool to limit repeat <i>Clostridioides difficile</i> toxin enzyme immunoassay testing on test utilizationJennie H Kwon, Kimberly A Reske, Tiffany Hink, et al.
Antimicrobial Agents and Chemotherapy|May 20, 2015
Risk Factors for Acquisition and Loss of Clostridium difficile Colonization in Hospitalized PatientsErik R Dubberke, Kimberly A Reske, Sondra Seiler, et al.
The Journal of Applied Laboratory Medicine|October 5, 2021
Alternative Causes of Infectious Diarrhea in Patients with Negative Tests for Clostridoides DifficileJennie H Kwon, Caroline A O'Neil, Tiffany Hink, et al.
Open Forum Infectious Diseases|March 11, 2020
Microbiome Restoration by RBX2660 Does Not Preclude Recurrence of Multidrug-Resistant Urinary Tract Infection Following Subsequent Antibiotic Exposure: A Case ReportEric C Keen, Preston Tasoff, Tiffany Hink, et al.
Infection Control and Hospital Epidemiology|September 19, 2018
Clostridium difficile colonization among patients with clinically significant diarrhea and no identifiable cause of diarrheaErik R Dubberke, Kimberly A Reske, Tiffany Hink, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Anaerobe|December 19, 2012
A systematic evaluation of methods to optimize culture-based recovery of Clostridium difficile from stool specimensTiffany Hink, Carey-Ann D Burnham, Erik R Dubberke
Journal of Clinical Microbiology|November 21, 2014
Comparison of chromogenic media for recovery of carbapenemase-producing enterobacteriaceae (CPE) and evaluation of CPE prevalence at a tertiary care academic medical centerMorgan A Pence, Tiffany Hink, Carey-Ann D Burnham
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 24, 2014
Prevalence and risk factors for asymptomatic Clostridium difficile carriageFaisal Alasmari, Sondra M Seiler, Tiffany Hink, et al.
Journal of Clinical Microbiology|December 9, 2016
Evaluation of Correlation between Pretest Probability for Clostridium difficile Infection and Clostridium difficile Enzyme Immunoassay ResultsJennie H Kwon, Kimberly A Reske, Tiffany Hink, et al.
Antimicrobial Agents and Chemotherapy|August 19, 2015
Ceftolozane-tazobactam activity against phylogenetically diverse Clostridium difficile strainsMark D Gonzalez, Meghan A Wallace, Tiffany Hink, et al.
Infection Control and Hospital Epidemiology|October 25, 2019
Impact of an electronic hard-stop clinical decision support tool to limit repeat <i>Clostridioides difficile</i> toxin enzyme immunoassay testing on test utilizationJennie H Kwon, Kimberly A Reske, Tiffany Hink, et al.
Antimicrobial Agents and Chemotherapy|May 20, 2015
Risk Factors for Acquisition and Loss of Clostridium difficile Colonization in Hospitalized PatientsErik R Dubberke, Kimberly A Reske, Sondra Seiler, et al.
The Journal of Applied Laboratory Medicine|October 5, 2021
Alternative Causes of Infectious Diarrhea in Patients with Negative Tests for Clostridoides DifficileJennie H Kwon, Caroline A O'Neil, Tiffany Hink, et al.
Open Forum Infectious Diseases|March 11, 2020
Microbiome Restoration by RBX2660 Does Not Preclude Recurrence of Multidrug-Resistant Urinary Tract Infection Following Subsequent Antibiotic Exposure: A Case ReportEric C Keen, Preston Tasoff, Tiffany Hink, et al.
Infection Control and Hospital Epidemiology|September 19, 2018
Clostridium difficile colonization among patients with clinically significant diarrhea and no identifiable cause of diarrheaErik R Dubberke, Kimberly A Reske, Tiffany Hink, et al.
Pageof 4